AzTrials
AzTrials

Postoperative Pain After Arthroscopic Knee SurgeryNCT07790393

Adductor Canal Block Versus Parasartorial Compartment Block for Pain Relief and Recovery After Arthroscopic Knee Surgery

A study testing Meperidine in people with Postoperative Pain After Arthroscopic Knee Surgery, run by Istanbul Medipol University Hospital at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to compare adductor canal block and parasartorial compartment block for pain relief and functional recovery in adults undergoing elective arthroscopic knee surgery. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Meperidine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
Sep 2026to Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Scheduled for elective unilateral primary arthroscopic knee surgery

Who cannot join

  • Revision or bilateral arthroscopic knee surgery
  • Surgery performed for trauma or an emergency indication
  • Contraindications to regional nerve block, including infection at the injection site, coagulopathy, or inappropriate anticoagulant use
  • Allergy to amide-type local anesthetics
  • Pre-existing peripheral neuropathy or motor deficit in the limb to be operated on
  • Dysfunction of the contralateral limb severe enough to interfere with functional assessments
Show all 9Show fewer
  • Chronic opioid use
  • Severe cognitive impairment
  • Pregnancy or lactation

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Fatma P Ucar, MD contact

+905377697281

fpinarucar@gmail.com

Turkey (Türkiye)1 site
  • Medipol Mega Hastaneler Kompleksi

    Istanbul, Bagcilar, 34214

    Fatma P Ucar, MD, +905377697281, fpinarucar@gmail.com

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of the Effects of Adductor Canal Block and Parasartorial Compartment Block on Postoperative Analgesia and Functional Recovery After Arthroscopic Knee Surgery: A Prospective, Randomized, Double-Blind Study

The goal of this clinical trial is to compare adductor canal block and parasartorial compartment block for pain relief and functional recovery in adults undergoing elective arthroscopic knee surgery. The main questions it aims to answer are:

Which block provides better pain relief at rest and during movement 24 hours after surgery? How do the two blocks compare in opioid use, muscle strength, knee movement, early walking, side effects, and patient satisfaction?

Read more

Researchers will compare participants who receive an adductor canal block with those who receive a parasartorial compartment block to determine whether one technique provides better pain relief and functional recovery while preserving muscle strength.

Participants will:

Be randomly assigned to receive either an ultrasound-guided adductor canal block or an ultrasound-guided parasartorial compartment block Have their pain at rest and during knee movement assessed for 48 hours after surgery Have their opioid use, quadriceps muscle strength, knee movement, walking ability, side effects, and satisfaction evaluated after surgery

Being tested
Meperidine
Keywords
Adductor Canal Block, Postoperative Pain, Parasartorial Compartment Block
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MeperidineDrug

    If the patient's NRS is 4 or more, 0.5 mg/kg meperidine will be given

Study groups in NCT07790393
Study groupRoleWhat they receive
Adductor Canal BlockActive comparatorNot described
Receives: Drug: Meperidine
Parasartorial Compartment BlockActive comparatorNot described
Receives: Drug: Meperidine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain at Rest 24 Hours After Surgery

    Pain intensity at rest will be assessed using the Numeric Rating Scale, ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Lower scores indicate less pain.

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Aug 2026
  2. Study startSep 2026 (estimated)
  3. Primary completionJun 2027 (estimated)
  4. Study completionJun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07790393
Sponsor's protocol ID
CemreTez
Status last verified
Aug 2026
First submitted
25 Aug 2026
Last updated
27 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be publicly shared because the informed consent process does not include consent for public data sharing and to protect participant confidentiality. Aggregated study results will be reported in scientific publications.

Publications

  • Gungor H, Atalay YO. Para-sartorial compartments (Pasc) block for knee surgeries: a report of five cases. Minerva Anestesiol. 2023 Jun;89(6):606-608. doi: 10.23736/S0375-9393.23.17124-0. Epub 2023 Feb 8. No abstract available.

    PubMed 36752608
  • Pascarella G, Costa F, Del Buono R, Strumia A, Cataldo R, Agro F, Carassiti M. The para-sartorial compartments (PASC) block: a new approach to the femoral triangle block for complete analgesia of the anterior knee. Anaesth Rep. 2022 May 5;10(1):e12165. doi: 10.1002/anr3.12165. eCollection 2022 Jan-Jun. No abstract available.

    PubMed 35547556
  • Espelund M, Grevstad U, Jaeger P, Holmich P, Kjeldsen L, Mathiesen O, Dahl JB. Adductor canal blockade for moderate to severe pain after arthroscopic knee surgery: a randomized controlled trial. Acta Anaesthesiol Scand. 2014 Nov;58(10):1220-7. doi: 10.1111/aas.12407.

    PubMed 25307707
  • Chen B, Tan M, Li Q, Wang S, Chen D, Zhao M, Cao J. Application of ultrasound-guided single femoral triangle and adductor canal block in arthroscopic knee surgery: a prospective, double-blind, randomized clinical study. BMC Anesthesiol. 2024 May 23;24(1):182. doi: 10.1186/s12871-024-02555-0.

    PubMed 38783177

Questions about this trial

What is this clinical trial studying?

A study testing Meperidine in people with Postoperative Pain After Arthroscopic Knee Surgery, run by Istanbul Medipol University Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 27 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Fatma P Ucar, MD (+905377697281, fpinarucar@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain at Rest 24 Hours After Surgery (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07790393, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in